Stadsholmen Equity acted as Lead Manager in Ella's Directed Share Issue

Today, women experience significant deficiencies in primary care related to their care before, during, and after pregnancy. At the same time, there aren't enough resources to prevent and treat the childbirth-related issues women face, which globally costs society well over SEK 1,000 billion annually.

Ella is a unique digital healthcare service and a CE-certified app that addresses this issue by offering personalized care and support before, during, and after pregnancy.

Their interdisciplinary healthcare team consists of licensed physiotherapists, psychologists, and dietitians specialized in women's health. They assist in preventing and treating common pregnancy-related problems through digital healthcare visits and individually tailored treatment programs.

Soon, Ella will expand its healthcare team and target audience, becoming the first in the world with medical software that prevents, diagnoses, and treats issues throughout women's lifecycle—from adolescence to menopause. This highly innovative automation will bring immense scalability and high gross margins, which, combined with the subscription service, means recurring revenue and increased visibility.

Since its launch in 2022, they have achieved very strong KPIs, such as customer satisfaction with an NPS of 96.1, 98% recurring customers, and an LTV/CAC of 3x—rising every day.

Stadsholmen Equity wants to thank Ella for their trust in us, and we look forward to following the company's future journey.